about
MRI reveals differential effects of amphetamine exposure on neuroglia in vivoWHY NOT POT?: A Review of the Brain-based Risks of CannabisMultifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literatureGlial modulators as potential treatments of psychostimulant abuseThe involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults.A potential role for creatine in drug abuse?Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controlsRapid analysis of abused drugs using nanostructured silicon surface assisted laser desorption/ionization mass spectrometry.Retrotransposition of long interspersed element 1 induced by methamphetamine or cocaine.Substance of abuse and movement disorders: complex interactions and comorbidities.The problem of axonal injury in the brains of veterans with histories of blast exposureInteractions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.A Cohort Pilot Study on HIV-Associated Neuropsychological Impairments in Hemophilia Patients.Phenylpropanolamine and the hemorrhagic stroke: A new search for the culpritPsychostimulant-Induced Testicular Toxicity in Mice: Evidence of Cocaine and Caffeine Effects on the Local Dopaminergic System.Brain-derived neurotrophic factor and neuropsychiatric disorders.Opiate drug use and the pathophysiology of neuroAIDS.Morphine Withdrawal Modifies Prion Protein Expression in Rat HippocampusA role for kalirin in the response of rat medium spiny neurons to cocaine.[CNS metabolism in high-risk drug abuse, German version : Insights gained from 1H- and 31P MRS and PET].Polysubstance and alcohol dependence: unique abnormalities of magnetic resonance-derived brain metabolite levelsMicrostructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.Structural imaging for addiction medicine: From neurostructure to neuroplasticityDNA methylation in Huntington's disease: Implications for transgenerational effectsIsolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study.Cytokines, chaperones and neuroinflammatory responses in heroin-related death: what can we learn from different patterns of cellular expression?Why is neuroimmunopharmacology crucial for the future of addiction research?Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?Reversible cerebral vasoconstriction syndrome: current and future perspectives.Traumatic white matter injury and toxic leukoencephalopathies.Dependent behavior in patients with medication-overuse headache.Kalirin, a key player in synapse formation, is implicated in human diseases.Neuropathology of substance use disorders.Neuroglia in ageing and disease.Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.Targeting voltage-gated calcium channels in neurological and psychiatric diseases.CNS metabolism in high-risk drug abuse : Insights gained from (1)H-, (31)P-MRS and PET.Methamphetamine induces the release of endothelin.Transitions and Motivations for Substance Misuse in Prison Inmates With ADHD and Conduct Disorder: Validation of a New Instrument.Drug-induced bilateral ischemic infarction in an amphetamine addict.
P2860
Q22065963-4C72316A-1585-4C26-89B8-ECF5C7C3A090Q26746122-2F89424F-84DA-4199-A008-554F0026CAFDQ26781744-41CF26C9-721B-46D7-8B1A-8B5C3FE6DF00Q28307030-64A77126-4036-418C-AA44-D3614A247988Q30441452-9F010EAB-DB83-404A-A7C6-FA8A3FCFEE4FQ33844763-5B9DBE09-CAE5-49AB-A7CB-D40A45D41C32Q33877067-0A40A220-2186-4B0F-BE0C-B50BC1CBECFDQ34092931-A74BD1E5-F9BE-4F31-8C96-9E314491EF9CQ34170616-61656310-F177-45B4-8486-9A85C2F12B10Q34303433-BAA2EF55-867E-4B14-BFA8-D225ABBEC453Q34659252-56C166C1-D831-4DA5-A781-4CCC364D57CEQ35007339-2B02EA80-5E1E-4FE4-9E29-D4B0444EE672Q35672791-63B4AF88-629D-4C52-AEF8-4D1E7A6CD67CQ35770633-2CB38015-DFA9-42EE-A204-24C1A338520AQ35839263-3E2F8A34-E6D9-401F-8D80-DD8AA7664F26Q35847085-9FD06033-ECCE-4249-B5E0-E9CB918D6D6DQ36201412-FADCD15C-6CA7-4122-A600-3CCE1F0127D9Q36247645-ABD7D89C-2BF8-4D53-93CF-2B96A40284D0Q36294402-7651CD9C-45E0-4B7C-BA51-61ABAAEE53F8Q36374522-6E6C22CC-4F8D-422A-8FFB-20C06878E9ABQ36759409-CEB8E151-AFEB-488A-9F76-DB6983FE86C5Q36797975-A977C24A-0EE5-4110-8A6B-EEF19DF269E3Q36867590-BD439FDE-0575-439B-A4FA-8538F5203ABBQ36892975-C57BC5B4-359F-43B8-A7EE-A9774F0406BCQ37273970-255CD761-D314-4D84-A157-4927BC7DE66EQ37291190-AE8B79C0-CCFD-4B61-8FD7-56F66DDEA043Q37381509-EA7F4F55-43BB-46CA-9E16-818AEB08A38FQ37630111-ADFE25AB-D204-4254-AD2A-2B3F5F0E2093Q37921763-EC4B596E-13A1-4ED5-8B03-DBE5A8E0C2E8Q37921766-4FD0A760-6784-473C-9C0C-022415BD9037Q37962457-4E20BCE7-75A3-477A-82D5-2235280A5C72Q38006709-F54C2B5F-6E12-41A2-AF8B-EB1938B251FAQ38167646-52DCDEE9-D6E5-44EE-94CA-85AC47F70253Q38197951-37CBA399-0155-4138-9EC7-6E1DB5ABE275Q38309143-CD92E635-76D0-4F44-AB39-31A6DA5E50FFQ38626606-22C76913-4F7F-4203-817D-80326C8FE4FEQ38659642-198A766E-7030-46B6-87B8-D66C221956FCQ38819553-BB7B8C79-1BE0-451C-B5E8-0413CDDEE0AAQ39248255-453F9AA8-13C9-4C75-87E5-A213E2B40FF2Q45980178-E540B492-844F-4CE5-B59E-CD0B9DD36228
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review: The neuropathology of drug abuse.
@en
Review: The neuropathology of drug abuse.
@nl
type
label
Review: The neuropathology of drug abuse.
@en
Review: The neuropathology of drug abuse.
@nl
prefLabel
Review: The neuropathology of drug abuse.
@en
Review: The neuropathology of drug abuse.
@nl
P2860
P1476
Review: The neuropathology of drug abuse
@en
P2093
P2860
P304
P356
10.1111/J.1365-2990.2010.01131.X
P577
2011-02-01T00:00:00Z